Skip to main content
Fig. 6 | BMC Immunology

Fig. 6

From: Optimized workflow to modify microRNA expression in primary human intravascular cells

Fig. 6

Expression of miR-15a-5p and miR-20b-5p in primary monocytes following transfection of the respective miRNA mimics. Monocytes were transfected with elevated concentration (0.45, 1.5, 5 and 16.7 nM) of mirVana miRNA mimic for A miR-15a-5p and C miR-20b-5p, or their respective scrambled control using Lipofectamine RNAiMAX as a carrier. In addition, monocytes were transfected with Lipofectamine RNAiMAX in complex with LNA miRNA mimic for B miR-15a-5p and D miR-20b-5p, or their respective scrambled control at elevated concentration (0.45, 1.5, 5 and 16.7 nM). Following 48 h, total RNAs were isolated and expression levels of miR-15a-5p, miR-20b-5p and reference miRNA miR-103a-3p were measured by qRT-PCR. Relative expression levels of miR-15a-5p and miR-20b-5p in comparison to miR-103a-3p were shown as mean ± SEM. N ≥ 3 experiments and N ≥ 3 technical replicates were performed

Back to article page